Frost & Sullivan

AUGUST 23, 2023

August 23, 2023 – Frost & Sullivan recently assessed the landscape for real-world evidence (RWE) information technology (IT) solutions for the healthcare industry and, based on its research results, recognizes Optum with the 2023 North American Company of the Year Award. SAN ANTONIO, TX.

Life science 52

Life science Biopharmaceuticals Biopharma Partnering capability and readiness 52

BTD Consulting

APRIL 11, 2022

The sponsorship agreement, which begins this year, will continue through 2023 and beyond. ASAP global, corporate, and individual members represent a wide variety of industries that include high tech, biopharma, life science, finance, fintech, insurance, energy, consulting, and many others. ASAP and its members have led this success.

Channels and alliances 52

Channels and alliances Biopharma Strategic alliances Alliance management 52

Frost & Sullivan

APRIL 25, 2023

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. years, to become a truly global company with a diverse mix of public sector and biopharma clients. SAN ANTONIO, TX.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

LaVoie Health Science Blog

APRIL 13, 2023

We recognize the need to provide a unique set of services to companies focused on the future of biopharma and medtech that are right sized to fit these companies’ unique communications needs in the current market,” said Donna L. LaVoie , President and CEO of LaVoieHealthScience.

Biopharma 52

Biopharma Business development 52

BTD Consulting

APRIL 11, 2022

The sponsorship agreement, which begins this year, will continue through 2023 and beyond. ASAP global, corporate, and individual members represent a wide variety of industries that include high tech, biopharma, life science, finance, fintech, insurance, energy, consulting, and many others. ASAP and its members have led this success.

Channels and alliances 40

Channels and alliances Biopharma Strategic alliances Alliance management 40

Frost & Sullivan

MARCH 16, 2025

of Competitors 80, with revenue greater than $1.0 billion, and Thermo Fisher acquired Olink for $3.1 of Competitors 80, with revenue greater than $1.0 billion, and Thermo Fisher acquired Olink for $3.1 Bruker acquired Prolabs proteomics capabilities.

Biopharma 52

Biopharma Strategic alliances Strategic partnership Ecosystems 52

Frost & Sullivan

JANUARY 23, 2025

While 2024 saw a 41% decline in aggregate deal value , falling from $222 billion in 2023 to $130 billion, 2025 is poised for a rebound. Notably, these transactions reflected a shift toward smaller, strategically targeted acquisitions addressing critical unmet needs. South Koreas Investments : Lotte Biologics invested $3.3

Biotechnology 52

Biotechnology Mergers and acquisition activities Biotech Biopharma 52